[Federal Register Volume 66, Number 193 (Thursday, October 4, 2001)]
[Notices]
[Page 50660]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-24837]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Director's Council of Public Representatives.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.
    Name of Committee: Director's Council of Public Representatives.
    Date: October 23, 2001.
    Time: 8:30 a.m. to 4:30 p.m.
    Agenda: Among the topics proposed for discussion are: (1) The 
science underlying complementary and alternative medicine; (2) human 
research protections; (3) technology transfer activities at the NIH: 
current issues; and (4) staff reports on NIH stem cell research 
activity.
    Place: National Institutes of Health, 9000 Rockville Pike, Building 
31, C Wing, Conf. Rm. 6, Bethesda, MD 20892.
    Contact Person: Jennifer E. Gorman, NIH Public Liaison/COPR 
Coordinator, Office of Communications and Public Liaison, Office of the 
Director, National Institutes of Health, 9000 Rockville Pike, Building 
1, Room 344, Bethesda, MD 20892, (301) 435-4448, [email protected].
    Information is also available on the Institute's/Center's home 
page: www.nih.gov/about/publicliaison/index.html, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Nos. 93.14, Intramural 
Research Training Award; 93.187, Undergraduate Scholarship Program 
for Individuals from Disadvantaged Backgrounds; 93.22, Clinical 
Research Loan Repayment Program for Individuals from Disadvantaged 
Backgrounds; 93.232, Loan Repayment Program for Research Generally; 
93.39, Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: September 26, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-24837 Filed 10-3-01; 8:45 am]
BILLING CODE 4140-01-M